TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review

References

• Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, et al. “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41(4): 589–98.
   PubMedGoogle Scholar
• Mosca M, Tani C, Carli L, Bombardieri S. Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol. 2012;26:73–7.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev. 2006;6:1–4.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Talarico R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev. 2011;10:256–8.
   PubMedGoogle Scholar
• Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999; 17:615–20.
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev. 2012;11:593–5.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Carli L, Bombardieri S. Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 2011;29:S126–9.
   PubMedGoogle Scholar
• Tani C, D’Aniello D, Sedie AD, Carli L, Cagnoni M, Possemato N, et al. Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2013;12(4):537–41.
   PubMed Web of Science ®Google Scholar
• Mosca M, Boumpas DT, Bruce IN, Cervera R, Czirjak L, Dörner T, et al. Treat-to-target in systemic lupus erythematosus: where are we today? Clin Exp Rheumatol. 2012;30:S112–5.
   PubMedGoogle Scholar
• Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. Clin Exp Rheumatol. 2012;30 (4 Suppl 73):S116–22.
   PubMedGoogle Scholar
• Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum. 2000;43:2383–90.
   PubMed Web of Science ®Google Scholar
• Aringer M, Smolen JS. Efficacy and safety of TNF blocker therapy in systemic lupus erythematosus. Expert Opin Drug Saf. 2008;7:411–9.
   PubMed Web of Science ®Google Scholar
• Soforo E, Baumgartner M, Francis L, Allam F, Phillips PE, Perl A. Induction of systemic lupus erythematosus with tumor necrosis factor blockers. J Rheumatol. 2010;37:204–5.
   PubMed Web of Science ®Google Scholar
• Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, et al. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology. 2009;48:1451–4.
   PubMed Web of Science ®Google Scholar
• Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum. 2004;50:3161–9.
   PubMed Web of Science ®Google Scholar
• Uppal SS, Hayat SJ, Raghupathy R. Efficacy and safety of infliximab in active SLE: a pilot study. Lupus. 2009;18:690–7.
   PubMed Web of Science ®Google Scholar
• Matsumura R, Umemiya K, Sugiyama T, Sueishi M, Umibe T, Ichikawa K, Yoshimura M;Study Group on Nephrology at the National Hospital Organization of Japan. Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients. Clin Exp Rheumatol. 2009;27:416–21.
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Yamamoto T, Asako K, Takayama M, Shirasaki R, Ono Y. Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus. Mod Rheumatol. 2012;22:308–11.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol. 2008;18:72–5.
   PubMed Web of Science ®Google Scholar
• Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81: 59–61.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, Ishigatsubo Y. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology. 2007;46:1621–22.
   PubMed Web of Science ®Google Scholar
• Micheloud D, Nuño L, Rodríguez-Mahou M, Sánchez-Ramón S, Ortega MC, Aguarón A, et al. Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy. Lupus. 2006; 15: 881–5.
   PubMed Web of Science ®Google Scholar
• Graff-Radford J, Robinson MT, Warsame RM, Matteson EL, Eggers SD, Keegan BM. Progressive multifocal leukoencephalopathy in a patient treated with etanercept. Neurologist. 2012;18:85–7.
   PubMed Web of Science ®Google Scholar
• Weyand CM. Immunopathologic aspects of rheumatoid arthritis: who is the conductor and who plays the immunologic instrument? J Rheumatol. 2007;79:9–14.
   Google Scholar
• Martini D, Baldini C, Latorre M, Giorgerini V, Sernissi F, Della Rossa A, Mosca M. Future prospects for salivary proteomics in rheumatology: the example of eosinophil granulomatosis with polyangiitis. Clin Exp Rheumatol. 2012;30:810–11.
   PubMedGoogle Scholar
• Gallo A, Baldini C, Teos L, Mosca M, Bombardieri S, Alevizos I. Emerging trends in Sjögren's syndrome: basic and translational research. Clin Exp Rheumatol. 2012;30:779–84.
   PubMed Web of Science ®Google Scholar